PACS Group said it is seeking a valuation of as much as $3.25 billion in its U.S. initial public offering, the latest in a string of firms looking to take advantage of improving investor interest for new stocks. The healthcare company is planning to sell 19.05 million shares priced between $20 and $22 each to raise about $419 million at the top of the range, according to a regulatory filing. Founded in 2013, PACS is a post-acute healthcare company primarily focused on delivering skilled nursing care through a portfolio of independently operated facilities.
Read the full article: Healthcare Firm PACS Group Eyes up to $3.25B Valuation in US IPO //
Source: https://www.reuters.com/markets/deals/healthcare-firm-pacs-group-eyes-up-325-bln-valuation-us-ipo-2024-04-01/